Physician profile
David Kishbaugh
NPI 1053374157
$8,911.67
in general payments reported to CMS, 2019-2025
17 companies · $1,354 in 2025
The $1,354 reported for 2025 was more than what 90% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $377 · 2021: $391 · 2022: $573 · 2023: $4,451 · 2024: $1,493 · 2025: $1,354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,873 · Travel and Lodging: $3,417 · Education: $7.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,873.23 |
| Travel and Lodging | $3,417.48 |
| Education | $7.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,814.51 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept, Superion Indirect Decompression System |
| Medtronic, INC. | $2,993.67 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Curonix LLC | $519.96 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $289.59 | 2023-2025 | Qutenza |
| Medtronic USA, INC. | $269.03 | 2019-2020 | |
| Grt US Holding, INC. | $249.72 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $239.58 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2020 | |
| Vertos Medical, INC. | $120.22 | 2022-2023 | Mild Device Kit |
| Nevro Corp. | $65.29 | 2022-2024 | Senza |
| Relievant Medsystems, INC. | $64.31 | 2023 | Intracept |
| Abbott Laboratories | $63.33 | 2024 | Octrode, Eterna |
| Merz Pharmaceuticals, LLC | $35.92 | 2023 | Xeomin |
| Abbvie INC. | $17.36 | 2024 | |
| Saluda Medical Americas, INC. | $15.44 | 2024 | Evoke |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $15.32 | 2020 | |
| Nalu Medical, INC. | $13.42 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kishbaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.